Hubei Xiangyuan New Material Technology Inc. (SHE:300980)

Intra-Cellular Therapies Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	3,107	3,085	2,541	1,899	3,039	-
Market Cap Growth	66.09%	21.40%	33.83%	-37.51%	-	-
Enterprise Value	2,849	3,212	2,385	1,516	2,584	-
Last Close Price	23.02	22.73	22.83	16.93	26.93	-
PE Ratio	97.11	120.64	61.96	33.51	34.64	-
Forward PE	-	17.66	17.66	16.01	30.63	-
PS Ratio	6.20	6.48	6.62	5.08	6.58	-
PB Ratio	2.22	2.21	2.45	1.99	3.31	-
P/TBV Ratio	2.34	2.33	2.64	2.17	3.61	-
P/OCF Ratio	3130.05	249.08	95.79	23.67	137.79	-
EV/Sales Ratio	5.69	6.75	6.22	4.06	5.59	-
EV/EBITDA Ratio	33.18	39.60	30.78	23.60	24.06	-
EV/EBIT Ratio	136.94	132.44	53.61	37.35	29.35	-
Debt / Equity Ratio	0.02	0.02	0.45	0.05	0.04	0.19
Debt / EBITDA Ratio	0.26	0.27	5.80	0.63	0.32	0.57
Debt / FCF Ratio	-	-	-	-	-	7.96
Asset Turnover	0.33	0.30	0.27	0.34	0.61	0.80
Inventory Turnover	4.33	5.15	4.91	5.69	7.99	6.46
Quick Ratio	4.54	4.52	3.95	2.79	5.76	1.24
Current Ratio	6.59	5.58	4.42	3.20	6.36	1.56
Return on Equity (ROE)	2.29%	2.10%	4.12%	6.05%	14.37%	27.60%
Return on Assets (ROA)	0.84%	0.94%	1.97%	2.29%	7.29%	13.93%
Return on Capital (ROIC)	0.92%	1.04%	2.23%	2.60%	8.37%	17.09%
Return on Capital Employed (ROCE)	1.40%	1.70%	3.00%	4.10%	9.30%	26.80%
Earnings Yield	0.88%	0.83%	1.61%	2.98%	2.89%	-
FCF Yield	-1.85%	-2.22%	-10.59%	-5.15%	-3.36%	-
Dividend Yield	0.78%	0.79%	0.79%	-	0.74%	-
Payout Ratio	124.84%	133.85%	45.23%	39.98%	2.13%	14.97%
Buyback Yield / Dilution	-9.94%	1.28%	-0.97%	-4.80%	-26.17%	-6.95%
Total Shareholder Return	-9.16%	2.08%	-0.17%	-4.80%	-25.42%	-6.95%

Updated Oct 27, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.